Login / Signup

Multicenter early United States feasibility study and periprocedural safety of LVIS EVO for the treatment of unruptured intracranial aneurysms.

Yasha KadkhodayanJosser E Delgado AlmandozAlexander CopelanCharles C MatoukM Imran ChaudryDavid J AltschulMuhammed Amir EssibayiOded GorenBenjamin YimSam TsappidiYi Jonathan ZhangFerdinand K HuiEdgar A SamaniegoAndres GudinoAdnan SiddiquiVinay JaikumarAjit S PuriAnna Luisa KuhnJasmeet SinghAndrew RingerRicardo A HanelOtavio Frederico De ToledoGuilherme DabusM Reid GoochSaman SizdahkhaniNicholas C FieldAlexandra R Paul
Published in: Journal of neurointerventional surgery (2024)
The LVIS EVO is a braided, self-expanding, retrievable stent with enhanced visibility and smaller cell size. The drawn filled tube (DFT) technology results in improved visibility of the stent, allowing for more controlled stent positioning and visualization of vessel wall apposition. All cases in our series had complete neck coverage and good wall apposition. There were no thromboembolic or hemorrhagic complications.
Keyphrases
  • single cell
  • inferior vena cava
  • cross sectional
  • middle cerebral artery
  • risk factors
  • density functional theory
  • clinical trial
  • coronary artery disease
  • mesenchymal stem cells
  • pulmonary embolism